Compile Data Set for Download or QSAR
Report error Found 42 Enz. Inhib. hit(s) with all data for entry = 50035364
LigandPNGBDBM50125195((S)-2-(2-Bromo-benzoylamino)-3-(3H-imidazol-4-yl)-...)
Affinity DataIC50: 750nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125215((S)-2-(2-Bromo-benzoylamino)-succinamic acid | CHE...)
Affinity DataIC50: 1.08E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125208((S)-2-(2-Bromo-benzoylamino)-3-(4-hydroxy-phenyl)-...)
Affinity DataIC50: 1.09E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125221((S)-6-Amino-2-(2-bromo-benzoylamino)-hexanoic acid...)
Affinity DataIC50: 1.21E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125228((S)-2-(2-Bromo-benzoylamino)-3-(1H-indol-3-yl)-pro...)
Affinity DataIC50: 1.70E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125194((S)-2-(2-Bromo-benzoylamino)-4-carbamoyl-butyric a...)
Affinity DataIC50: 1.77E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125232((S)-2-(2-Bromo-benzoylamino)-5-guanidino-pentanoic...)
Affinity DataIC50: 2.71E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125196((S)-2-(2-Bromo-benzoylamino)-3-(5-methoxy-1H-indol...)
Affinity DataIC50: 2.77E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50366858(CHEMBL1793834)
Affinity DataIC50: 3.84E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125220((R)-2-(2-Bromo-benzoylamino)-3-mercapto-propionic ...)
Affinity DataIC50: 4.26E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125217((S)-2-(2-Bromo-benzoylamino)-3-phenyl-propionic ac...)
Affinity DataIC50: 4.89E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125206((S)-2-(2-Bromo-benzoylamino)-4-phenyl-butyric acid...)
Affinity DataIC50: 5.09E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125198((S)-2-(2-Bromo-benzoylamino)-3-thiophen-2-yl-propi...)
Affinity DataIC50: 5.50E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125212((S)-2-(2-Bromo-benzoylamino)-3-hydroxy-propionic a...)
Affinity DataIC50: 6.15E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125204((S)-2-(2-Bromo-benzoylamino)-propionic acid | CHEM...)
Affinity DataIC50: 6.64E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125218((S)-2-(2-Bromo-benzoylamino)-4-methylsulfanyl-buty...)
Affinity DataIC50: 7.46E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125233((S)-2-(2-Bromo-benzoylamino)-3-(6-fluoro-1H-indol-...)
Affinity DataIC50: 7.64E+3nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125219((S)-2-(2-Bromo-benzoylamino)-3-(5-fluoro-1H-indol-...)
Affinity DataIC50: 1.08E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125229((S)-2-(2-Bromo-benzoylamino)-3-methyl-butyric acid...)
Affinity DataIC50: 1.13E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125235((S)-2-(2-Bromo-benzoylamino)-3-naphthalen-1-yl-pro...)
Affinity DataIC50: 1.60E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125227((S)-2-(2-Bromo-benzoylamino)-3-(5-hydroxy-1H-indol...)
Affinity DataIC50: 2.42E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125201((S)-2-(2-Bromo-benzoylamino)-3-naphthalen-2-yl-pro...)
Affinity DataIC50: 2.44E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125197((S)-2-(2-Bromo-benzoylamino)-3-(5-bromo-1H-indol-3...)
Affinity DataIC50: 2.84E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125202((S)-2-(2-Bromo-benzoylamino)-pentanedioic acid | C...)
Affinity DataIC50: 3.01E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125230((S)-2-(2-Bromo-benzoylamino)-3-(4-cyano-phenyl)-pr...)
Affinity DataIC50: 3.68E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125231((S)-3-Biphenyl-4-yl-2-(2-bromo-benzoylamino)-propi...)
Affinity DataIC50: 5.05E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125224((S)-2-(2-Bromo-benzoylamino)-4-methyl-pentanoic ac...)
Affinity DataIC50: 5.43E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125205((R)-2-(2-Bromo-benzoylamino)-propionic acid | CHEM...)
Affinity DataIC50: 5.75E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125216((S)-2-(2-Bromo-benzoylamino)-3-(1H-pyrrolo[2,3-b]p...)
Affinity DataIC50: 6.38E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125214((R)-2-(2-Bromo-benzoylamino)-3-hydroxy-propionic a...)
Affinity DataIC50: 7.26E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125234((R)-2-(2-Bromo-benzoylamino)-3-(1H-indol-3-yl)-pro...)
Affinity DataIC50: 7.66E+4nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125210((2S,3S)-2-(2-Bromo-benzoylamino)-3-methyl-pentanoi...)
Affinity DataIC50: 1.06E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125225(2-Bromo-N-[(S)-1-hydroxycarbamoyl-2-(1H-indol-3-yl...)
Affinity DataIC50: 1.40E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125209((S)-2-(2-Bromo-benzoylamino)-succinic acid | CHEMB...)
Affinity DataIC50: 2.00E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125207((R)-2-(2-Bromo-benzoylamino)-3-naphthalen-1-yl-pro...)
Affinity DataIC50: 2.00E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125223((R)-2-(2-Bromo-benzoylamino)-3-naphthalen-2-yl-pro...)
Affinity DataIC50: 2.43E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125222((R)-2-(2-Bromo-benzoylamino)-3-phenyl-propionic ac...)
Affinity DataIC50: 2.80E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125199((2-Bromo-benzoylamino)-acetic acid | CHEMBL7664)
Affinity DataIC50: 3.14E+5nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125211((S)-1-(2-Bromo-benzoyl)-pyrrolidine-2-carboxylic a...)
Affinity DataIC50: 1.00E+6nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125213(2-Bromo-N-[(S)-1-carbamoyl-2-(1H-indol-3-yl)-ethyl...)
Affinity DataIC50: 1.00E+6nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125200((S)-2-(2-Bromo-benzoylamino)-3-(1H-indol-3-yl)-pro...)
Affinity DataIC50: 1.00E+6nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed
LigandPNGBDBM50125203(2-Bromo-N-[2-(1H-indol-3-yl)-ethyl]-benzamide | CH...)
Affinity DataIC50: 1.00E+6nMAssay Description:Concentration required to inhibit binding of ICAM-1 to LFA-1 (Leukocyte function-associated antigen-1), evaluated ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2012
Entry Details Article
PubMed